SMTI
Sanara·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 5
Bearish signal 1
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SMTI
Sanara Medtech Inc.
A provider of products and technologies for surgical and chronic wound care
Healthcare Equipment and Supplies
12/14/2001
11/02/2020
NASDAQ Stock Exchange
141
12-31
Common stock
1200 Summit Avenue
, Suite 414 Fort Worth
, Texas 76102
--
Sanara Medtech Inc., established on December 14, 2001, is a Texas company named Eappuince Innovations, Inc., whose business is to develop, market and distribute wound and skin care products to physicians, hospitals, clinics and emergency rooms. The company's products are mainly sold to the North American advanced wound care and surgical tissue repair markets.
Earnings Call
Q2/2025
Estimate EPS--
Actual EPS-0.23
Estimate Revenue25.15M
Actual Revenue25.83M
Sanara MedTech's 2025 Q2 Earnings Call: Navigating Contradictions in Margins, Strategy, and Operational Investments
Aug 13,2025 02:58
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SMTI has released its 2025 Q3 earnings. EPS was reported at -3.4, versus the expected -0.22, missing expectations. The chart below visualizes how SMTI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SMTI has released its 2025 Q3 earnings report, with revenue of 26.33M, reflecting a YoY change of 21.51%, and net profit of -30.41M, showing a YoY change of -954.86%. The Sankey diagram below clearly presents SMTI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
